에 대한 최신 뉴스 SWK Holdings (NASDAQ:SWKH) 주식

SWK Holdings

SWK Holdings Corp is a healthcare capital provider. The company offers financing solutions to various life science companies, institutions, and inventors. It involves monetizing cash flow streams derived from commercial-stage products and related intellectual property through royalty purchases and financings, as well as through the creation of synthetic revenue interests in commercialized products. Through its wholly-owned subsidiary, it also provides non-discretionary investment advisory services to institutional clients. The company's operating segments are Finance Receivables and Pharmaceutical Development Services. It generates maximum revenue from the Finance Receivables segment.

SWK Holdings Corp

SWK Holdings Corporation - 9.00% Senior Notes due 2027

Earnings

Press Releases

SWK Holdings Corporation Announces Financial Results for Third Quarter 2024

News

SWK Holdings Provides Portfolio Update

Biodexa Strengthens Management Team - Appointment of Dr Gary A. Shangold as Chief Medical Officer

ImpediMed Secures $15m Growth Capital Funding

SWK Holdings Announces Fourth Quarter and Full Year 2024 Earnings Release Date and Conference Call

SWK Holdings Corporation Announces Financial Results for Fourth Quarter 2024

SWK Holdings Announces Monetization of Royalty Portfolio

SWK Holdings Announces Closing of Royalty Sale and $4.00 Per Share Special Dividend

SWK Holdings Announces First Quarter 2025 Earnings Release Date and Conference Call

SWK Holdings Corporation Announces Financial Results for First Quarter 2025

BDRX

SWKH

Acacia Research Corporation - Common Stock

Acacia Research

Eason Technology Limited American Depositary Shares (each representing sixty-thousand (60,000) Ordinary Shares)

Comments

SWK Holdings

뉴스

에 대한 최신 뉴스 SWK Holdings (NASDAQ:SWKH) 주식

사람들이 또한 지켜본다

뉴스

파트너 / 기고자

벤징가 글로벌